Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 14Gastrointestinal 7Other hematologic neoplasm 4Thoracic 3Myeloid 2Lymphoid 2CNS 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1Classical hematology 1Breast 1

Conditions

Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Induction Chemotherapy × Tumor-Agnostic × Clear all
NCT00770393 2008-10-10

Laryngeal Preservation in Pyriform Sinus Carcinoma

Centre Hospitalier Universitaire de Saint Etienne

Phase 2/3 Completed
71 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡